发明申请
US20130065911A1 N-(5-CYCLOALKYL- OR 5-HETEROCYCLYL-)-PYRIDIN-3-YL CARBOXAMIDES
失效
N-（5-环丙基 - 或5-杂环基 - ） - 吡啶-3-基羧酸酯
- 专利标题： N-(5-CYCLOALKYL- OR 5-HETEROCYCLYL-)-PYRIDIN-3-YL CARBOXAMIDES
- 专利标题（中）： N-（5-环丙基 - 或5-杂环基 - ） - 吡啶-3-基羧酸酯
-
申请号： US13607859申请日： 2012-09-10
-
公开(公告)号： US20130065911A1公开(公告)日： 2013-03-14
- 发明人: Uwe Grether , Stephan Roever
- 申请人： Uwe Grether , Stephan Roever
- 优先权： EP11180930.7 20110912
- 主分类号： C07D401/12
- IPC分类号： C07D401/12 ; A61K31/4439 ; A61P3/06 ; C07D213/74 ; A61K31/4418 ; A61K31/506 ; A61K31/444 ; C07D413/12
摘要：
The present invention relates to compounds of the formula wherein R1 to R3 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
公开/授权文献
- US08455501B2 N-(5-cycloalkyl)-pyridin-3-yl carboxamides 公开/授权日：2013-06-04
信息查询
